Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_assertion type Assertion NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_head.
- NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_provenance.
- NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_assertion evidence source_evidence_literature NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_provenance.
- NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_assertion SIO_000772 22587513 NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_provenance.
- NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_assertion wasDerivedFrom befree-20150227 NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_provenance.
- NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_assertion wasGeneratedBy ECO_0000203 NP882973.RAlOYE5RJNGDbOCH1G2E7J1xMuTmWvjm7iPF7eCrDdbeQ130_provenance.